MedPath

DAFLON 500mg comprimidos recubiertos

DAFLON 500mg comprimidos recubiertos

Pending
Register Number

4691-2004IP2

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Nov 19, 2014

Dosage Form

COMPRIMIDO RECUBIERTO

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number4691-2004IP2
EMA Approved
No

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (2)

DIOSMINAActive
Quantity: 450 mg
Name: DIOSMINA
HESPERIDINAActive
Quantity: 50 mg
Name: HESPERIDINA

ATC CLASSIFICATION (3)

C05C
C05CA
C05CA53

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.